Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021

神経血管用機器/インターベンショナル神経学の世界市場予測(~2021年)

◆タイトル:Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021
◆商品コード:MAM-MD1310
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年3月1日
◆ページ数:195
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、神経血管用機器/インターベンショナル神経学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、市場環境分析、製品別分析、病理学別分析、地域別分析、神経血管用機器/インターベンショナル神経学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global neurovascular devices/interventional neurology market is estimated reach USD 2.62 million at a CAGR of 8.6% during 2016-2021. As of 2016, North America and Europe holds the largest share of the market; however, the Asia-Pacific region is poised to be the fastest growing region during next five years owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, ongoing government initiatives to modernize & expand healthcare infrastructure, and increasing adoption of neurovascular devices due to decreasing product price (owing to increasingly localized manufacturing and strengthening of distribution networks).
Market growth in the market is mainly driven by factors such as large target patient population base, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets and growing market demand for effective neurovascular devices. The factors such as the increasing number of research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures are expected to offer renewed growth opportunities for the market players during the forecast period.

Geographically, North America is estimated to command the largest share of the global market in 2016, followed by Europe. The large market share of the North American region can be attributed to increasing adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, the growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices in specific disease treatment), significant medical reimbursement available in the U.S. for neurosurgical procedures, large patient population for target diseases, favorable reimbursement scenario, strong presence of device manufacturers in the region, and availability of significant R&D investments to support neurovascular product development. However, market growth will be negatively affected due to the unfavorable regulatory scenario in the region, which may result in increased pricing pressure on key neurovascular device manufacturers.

The market is highly competitive, with a large number of global and local manufacturers of neurovascular products. Stryker Corporation (U.S.), Medtronic Plc (Ireland), and Johnson & Johnson (U.S.) were the top three players in the market, in 2015.

Report Objective:
This report studies neurovascular devices/interventional neurology market based on products, disease pathology, and region.

The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the neurovascular devices/interventional neurology market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the neurovascular devices/interventional neurology market.

Reasons to buy the report:

From an insights perspective, this research report is focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together discuss basic views on the competitive landscape, emerging and high growth segments of the neurovascular devices/interventional neurology market, and high growth regions and their respective drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the major players in the neurovascular devices/interventional neurology market. The report analyzes the market based on product, disease pathology, and region.

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the neurovascular devices/interventional neurology market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various neurovascular devices/interventional neurology products across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices/interventional neurology market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the neurovascular devices/interventional neurology market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Breakdown of primaries 23
2.2 OPPORTUNITY INDICATORS 23
2.2.1.1 Target disease prevalence 24
2.2.1.2 Rising geriatric population 25
2.2.1.3 Number of hospitals and surgical centers 27
2.2.1.4 Healthcare expenditure 28
2.2.1.5 Number of clinical researches 30
2.3 MARKET SIZE ESTIMATION 30
2.3.1 BOTTOM-UP APPROACH 31
2.3.2 TOP-DOWN APPROACH 32
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.5 RESEARCH ASSUMPTIONS 34
2.5.1 ASSUMPTIONS 34

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 40
4.1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW 40
4.2 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET, BY REGION (2016 VS. 2021) 41
4.3 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET (2016 VS. 2021) 42
4.4 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY DISEASE PATHOLOGY, BY REGION (2016-2021) 43
4.5 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY (2016 VS. 2021) 44

5 MARKET OVERVIEW 45
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 KEY MARKET DRIVERS 47
5.2.1.1 Large target patient population 47
5.2.1.2 Ongoing product development and commercialization 48
5.2.1.3 Favorable medical reimbursements 49
5.2.1.4 Expansion of healthcare infrastructure across emerging markets 49
5.2.1.5 Growing market demand for effective neurovascular devices 50
5.2.2 KEY MARKET RESTRAINTS 51
5.2.2.1 Stringent regulatory scenario 51
5.2.2.2 Dearth of skilled neurosurgeons 52
5.2.3 KEY MARKET OPPORTUNITIES 52
5.2.3.1 Increasing number of research activities in the field of neurovascular therapies 52
5.2.3.2 Rising demand for minimally invasive neurosurgical procedures 53
5.3 ONGOING CLINICAL STUDIES 55
5.3.1 EMBOLIZATION COILING PROCEDURES 55
5.3.2 CAROTID ARTERY STENTING PROCEDURES 59
5.3.3 EMBOLIC PROTECTION PROCEDURES 66
5.3.4 FLOW DIVERSION PROCEDURES 68
5.3.5 SUPPORTING TECHNIQUES 70
5.3.6 NEUROTHROMBECTOMY PROCEDURES 71

6 INDUSTRY INSIGHTS 74
6.1 INTRODUCTION 74
6.2 SUPPLY CHAIN ANALYSIS 74
6.3 PORTER’S FIVE FORCES ANALYSIS 75
6.4 INDUSTRY TRENDS 76
6.4.1 INCREASING SURGEON’S AWARENESS RELATED TO BENEFITS OF STEREOTACTIC FRAMEWORK PROCEDURES IN NEUROSURGERIES 76
6.4.2 CHANNEL OPTIMIZATION 77

7 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT 78
7.1 INTRODUCTION 79
7.2 ANEURYSM COILING & EMBOLIZATION DEVICES 81
7.2.1 EMBOLIC COILS 84
7.2.1.1 Bare detachable coils 86
7.2.1.2 Coated detachable coils 87
7.2.2 FLOW DIVERSION DEVICES 88
7.2.3 LIQUID EMBOLIC AGENTS 89
7.3 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 91
7.3.1 CAROTID ARTERY STENTS 93
7.3.2 EMBOLIC PROTECTION SYSTEMS 95
7.3.2.1 Distal filter devices 96
7.3.2.2 Balloon occlusion devices 97
7.4 SUPPORT DEVICES 99
7.4.1 MICROCATHETERS 101
7.4.2 MICROGUIDEWIRES 103
7.5 NEUROTHROMBECTOMY DEVICES 104
7.5.1 CLOT RETRIEVAL DEVICES 106
7.5.2 SUCTION AND ASPIRATION DEVICES 107
7.5.3 SNARES 109

8 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY 110
8.1 INTRODUCTION 111
8.2 ISCHEMIC STROKES 112
8.3 CEREBRAL ANEURYSMS 114
8.4 ARTERIOVENOUS MALFORMATION AND FISTULAS 115
8.5 OTHER DISEASE PATHOLOGIES 116

9 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY REGION 117
9.1 INTRODUCTION 118
9.2 NORTH AMERICA 119
9.2.1.1 U.S. 124
9.2.1.2 Canada 124

9.3 EUROPE 125
9.3.1.1 Germany 130
9.3.1.2 France 131
9.3.1.3 U.K. 131
9.3.1.4 Rest of Europe 132
9.4 ASIA-PACIFIC 133
9.4.1.1 Japan 138
9.4.1.2 China 138
9.4.1.3 India 139
9.4.1.4 Rest of Asia-Pacific 140
9.5 REST OF THE WORLD 140

10 COMPETITIVE LANDSCAPE 144
10.1 OVERVIEW 144
10.2 MARKET SHARE ANALYSIS 145
10.3 COMPETITIVE SCENARIO 147
10.4 RECENT DEVELOPMENTS 148
10.4.1 PRODUCT LAUNCHES 148
10.4.2 STRATEGIC ACQUISITIONS 149
10.4.3 EXPANSIONS 150
10.4.4 AGREEMENTS AND COLLABORATIONS 151
10.4.5 OTHER DEVELOPMENTS 152

11 COMPANY PROFILES 153
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 INTRODUCTION 153
11.1.1 GEOGRAPHIC BENCHMARKING 153
11.2 STRYKER CORPORATION 154
11.3 MEDTRONIC PLC 157
11.4 JOHNSON & JOHNSON 162
11.5 TERUMO CORPORATION 165
11.6 PENUMBRA, INC. 169
11.7 BOSTON SCIENTIFIC CORPORATION 172
11.8 MICROPORT SCIENTIFIC CORPORATION 174
11.9 MERIT MEDICAL SYSTEMS, INC. 176
11.10 W.L. GORE & ASSOCIATES, INC. 179
11.11 ABBOTT LABORATORIES 180
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

12 APPENDIX 182
12.1 INSIGHTS OF INDUSTRY EXPERTS 182
12.2 DISCUSSION GUIDE 183
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 188
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 190
12.5 AVAILABLE CUSTOMIZATIONS 191
12.6 RELATED REPORTS 192
12.7 AUTHOR DETAILS 193

LIST OF TABLES

TABLE 1 EMBOLIZATION COILS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 55
TABLE 2 CAROTID STENTS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 59
TABLE 3 DISTAL FILTER AND BALLOON OCCLUSION CATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 66
TABLE 4 FLOW DIVERSION DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 68
TABLE 5 MICROCATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 70
TABLE 6 CLOT RETRIEVAL, SUCTION, AND ASPIRATION DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016) 71
TABLE 7 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 79
TABLE 8 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 80
TABLE 9 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (UNITS) 80
TABLE 10 GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 82
TABLE 11 GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014–2021 (UNITS) 83
TABLE 12 GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 83
TABLE 13 GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 85
TABLE 14 GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET VOLUME FOR EMBOLIC COILS, BY TYPE, 2014–2021 (UNITS) 85
TABLE 15 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2014–2021 (USD MILLION) 85
TABLE 16 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR BARE DETACHABLE COILS, BY REGION, 2014–2021 (USD MILLION) 86
TABLE 17 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET VOLUME FOR BARE DETACHABLE COILS, BY REGION, 2014–2021 (UNITS) 86
TABLE 18 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR COATED DETACHABLE COILS, BY REGION, 2014–2021 (USD MILLION) 87
TABLE 19 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET VOLUME FOR COATED DETACHABLE COILS, BY REGION, 2014–2021 (UNITS) 88
TABLE 20 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2014–2021 (USD MILLION) 89
TABLE 21 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET VOLUME FOR FLOW DIVERSION DEVICES, BY REGION, 2014–2021 (UNITS) 89
TABLE 22 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2014–2021 (USD MILLION) 90
TABLE 23 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET VOLUME FOR LIQUID EMBOLIC AGENTS, BY REGION, 2014–2021 (UNITS) 90
TABLE 24 GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 91
TABLE 25 GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (UNITS) 92
TABLE 26 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 92
TABLE 27 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2014–2021 (USD MILLION) 94
TABLE 28 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET VOLUME FOR CAROTID ARTERY STENTS, BY REGION, 2014–2021 (UNITS) 94
TABLE 29 GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE FOR EMBOLIC PROTECTION SYSTEMS, BY TYPE, 2014–2021 (USD MILLION) 95
TABLE 30 GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET VOLUME FOR EMBOLIC PROTECTION SYSTEMS, BY TYPE, 2014–2021 (UNITS) 95
TABLE 31 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE FOR EMBOLIC PROTECTION SYSTEMS, BY REGION, 2014–2021 (USD MILLION) 96
TABLE 32 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE FOR DISTAL FILTER DEVICES, BY REGION, 2014–2021 (USD MILLION) 97
TABLE 33 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET VOLUME FOR DISTAL FILTER DEVICES, BY REGION, 2014–2021 (UNITS) 97
TABLE 34 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE FOR BALLOON OCCLUSION DEVICES, BY REGION, 2014–2021 (USD MILLION) 98
TABLE 35 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET VOLUME FOR BALLOON OCCLUSION DEVICES, BY REGION, 2014–2021 (UNITS) 98
TABLE 36 GLOBAL NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 99
TABLE 37 GLOBAL NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (UNITS) 100
TABLE 38 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 100
TABLE 39 MICROCATHETERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 102
TABLE 40 MICROCATHETERS MARKET SIZE, BY REGION, 2014–2021 (UNITS) 102
TABLE 41 MICROGUIDEWIRES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 103
TABLE 42 MICROGUIDEWIRES MARKET SIZE, BY REGION, 2014–2021 (UNITS) 103
TABLE 43 GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 104
TABLE 44 GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE,
2014–2021 (UNITS) 105
TABLE 45 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 105
TABLE 46 NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 107
TABLE 47 NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2014–2021 (UNITS) 107
TABLE 48 NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 108
TABLE 49 NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE,
BY REGION, 2014–2021 (UNITS) 108
TABLE 50 NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 109
TABLE 51 NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION, 2014–2021 (UNITS) 109
TABLE 52 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014–2021 (USD MILLION) 111
TABLE 53 GLOBALNEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY DISEASE PATHOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 111
TABLE 54 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ISCHEMIC STROKES, BY REGION, 2014–2021 (USD MILLION) 113
TABLE 55 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CEREBRAL ANEURYSMS, BY REGION, 2014–2021 (USD MILLION) 114
TABLE 56 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ARTERIOVENOUS MALFORMATION AND FISTULAS, BY REGION,
2014–2021 (USD MILLION) 115
TABLE 57 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2014–2021 (USD MILLION) 116
TABLE 58 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 118
TABLE 59 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 119
TABLE 60 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCTS, 2014–2021 (USD MILLION) 120
TABLE 61 NORTH AMERICA: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT , 2014–2021 (USD MILLION) 120
TABLE 62 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 121
TABLE 63 NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 121
TABLE 64 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 122
TABLE 65 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014–2021 (USD MILLION) 122
TABLE 66 U.S.: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 124
TABLE 67 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 125
TABLE 68 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 126
TABLE 69 EUROPE: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCTS, 2014–2021 (USD MILLION) 126
TABLE 70 EUROPE: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 127
TABLE 71 EUROPE: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT , 2014–2021 (USD MILLION) 127
TABLE 72 EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT ,
2014–2021 (USD MILLION) 127
TABLE 73 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 128
TABLE 74 EUROPE: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY DISEASE PATHOLOGY, 2014–2021 (USD MILLION) 128
TABLE 75 GERMANY: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 130
TABLE 76 FRANCE: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 131
TABLE 77 U.K.: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 132
TABLE 78 ROE: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 133
TABLE 79 ASIA-PACIFIC: NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 134
TABLE 80 ASIA-PACIFIC: NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCTS, 2014–2021 (USD MILLION) 135
TABLE 81 ASIA-PACIFIC: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT , 2014–2021 (USD MILLION) 135
TABLE 82 ASIA-PACIFIC: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT , 2014–2021 (USD MILLION) 135
TABLE 83 ASIA-PACIFIC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 136
TABLE 84 ASIA-PACIFIC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 136
TABLE 85 ASIA-PACIFIC: NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PATHOLOGY, 2014–2021 (USD MILLION) 136
TABLE 86 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 138
TABLE 87 CHINA: NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 139
TABLE 88 INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 139
TABLE 89 ROAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 140
TABLE 90 ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCTS, 2014–2021 (USD MILLION) 141
TABLE 91 ROW: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2014–2021 (USD MILLION) 141
TABLE 92 ROW: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 141
TABLE 93 ROW: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 142
TABLE 94 ROW: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 142
TABLE 95 ROW: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2014–2021 (USD MILLION) 142
TABLE 96 TOP PRODUCT LAUNCHES (2013–2016) 148
TABLE 97 TOP STRATEGIC ACQUISITIONS (2013–2016) 149
TABLE 98 TOP EXPANSIONS (2013–2016) 150
TABLE 99 TOP AGREEMENTS AND COLLABORATIONS (2013–2016) 151
TABLE 100 OTHER DEVELOPMENTS (2013–2016) 152


LIST OF FIGURES

FIGURE 1 GLOBAL NEUROVASCULAR DEVICES?INTERVENTIONAL NEUROLOGY MARKET SEGMENTATION 17
FIGURE 2 RESEARCH DESIGN 20
FIGURE 3 PREVALENCE OF STROKE BY COUNTRY: AS OF 2015 24
FIGURE 4 INCREASE IN GERIATRIC POPULATION: BY COUNTRY (2010–2015) 25
FIGURE 5 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION: BY COUNTRY (2011–2030) 26
FIGURE 6 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION
(1980-2010 VS. 2010–2040) 27
FIGURE 7 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000 VS. 2014 28
FIGURE 8 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000 VS. 2014 28
FIGURE 9 HEALTHCARE SPENDING MATRIX: KEY MARKETS (2014) 29
FIGURE 10 BOTTOM-UP APPROACH 31
FIGURE 11 TOP-DOWN APPROACH 32
FIGURE 12 DATA TRIANGULATION 33
FIGURE 13 ASSUMPTIONS OF THE RESEARCH STUDY 34
FIGURE 14 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT (2016 VS. 2021) 36
FIGURE 15 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PATHOLOGY (2016 VS. 2021) 37
FIGURE 16 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY REGION (2016 VS. 2021) 38
FIGURE 17 NORTH AMERICA TO DOMINATE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY INDUSTRY DURING THE FORECAST PERIOD 39
FIGURE 18 GROWING TARGET PATIENT POPULATION TO PROPEL MARKET DEMAND FOR INTERVENTIONAL NEUROLOGY PRODUCTS DURING THE FORECAST PERIOD 40
FIGURE 19 ANEURYSM COILING & EMBOLIZATION DEVICES SEGMENT TO DOMINATE INTERVENTIONAL NEUROLOGY PRODUCT MARKET TILL 2021 41
FIGURE 20 EMBOLIC COILS TO BE HIGHEST CONTRIBUTING PRODUCT SEGMENT OF INTERVENTIONAL NEUROLOGY MARKET DURING 2016-2021 (USD MILLION) 42
FIGURE 21 ISCHEMIC STROKE SEGMENT TO LEAD THE MARKET DEMAND GROWTH FOR INTERVENTIONAL NEUROLOGY PRODUCTS DURING 2016-2021 43
FIGURE 22 CHINA AND INDIA POISED TO BE THE FASTEST GROWING COUNTRIES IN INTERVENTIONAL NEUROLOGY MARKET DURING 2016-2021 44
FIGURE 23 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 24 PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020) 48
FIGURE 25 GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE:
DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2014) 50
FIGURE 26 ONGOING CLINICAL TRIALS IN THE FIELD OF INTERVENTIONAL NEUROLOGY ACROSS THE GLOBE (AS OF DECEMBER 2016) 53
FIGURE 27 SUPPLY CHAIN ANALYSIS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY INDUSTRY (AS OF 2016) 74
FIGURE 28 PORTER’S FIVE FORCES ANALYSIS (2016): GROWING ADOPTION OF NEUROVASCULAR PRODUCTS IS TRANSLATING INTO HIGHER MARKET DEMAND 75
FIGURE 29 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS TO WITNESS HIGHEST MARKET GROWTH DURING 2016-2021 81
FIGURE 30 EMBOLIC COILS SEGMENT IS EXPECTED TO LEAD ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET GROWTH DURING THE FORECAST PERIOD 84
FIGURE 31 CAROTID ARTERY STENTS SEGMENT TO WITNESS HIGHEST GROWTH IN THE CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET TILL 2021 93
FIGURE 32 MICROCATHETERS ARE EXPECTED TO HOLD THE LARGEST SHARE OF SUPPORTING DEVICES MARKET DURING THE FORECAST PERIOD 101
FIGURE 33 CLOT RETRIEVERS TO WITNESS SIGNIFICANT MARKET GROWTH IN OVERALL NEUROTHROMBECTOMY DEVICES INDUSTRY DURING 2016-2021 106
FIGURE 34 ISCHEMIC STROKE IS POISED TO BE THE FASTEST GROWING DISEASE PATHOLOGY SEGMENT IN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DURING 2016-2021 112
FIGURE 35 NORTH AMERICA IS EXPECTED TO DOMINATE INTERVENTIONAL NEUROLOGY MARKET FOR ISCHEMIC STROKE TREATMENT TILL 2021 113
FIGURE 36 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 123
FIGURE 37 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 129
FIGURE 38 ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 137
FIGURE 39 REST OF THE WORLD: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 143
FIGURE 40 PRODUCT LAUNCHES & COMMERCIALIZATION: KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS FROM 2013 TO 2016 144
FIGURE 41 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, KEY PLAYER (2015) 145
FIGURE 42 GROWING NUMBER OF PRODUCT LAUNCHES AND ENHANCEMENTS IS DRIVING THE MARKET GROWTH 147
FIGURE 43 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS 153
FIGURE 44 STRYKER CORPORATION: COMPANY SNAPSHOT (2015) 154
FIGURE 45 MEDTRONIC PLC: COMPANY SNAPSHOT (2015) 157
FIGURE 46 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015) 162
FIGURE 47 TERUMO CORPORATION: COMPANY SNAPSHOT (2015) 165
FIGURE 48 PENUMBRA, INC.: COMPANY SNAPSHOT (2015) 169
FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015) 172
FIGURE 50 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015) 174
FIGURE 51 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2015) 176
FIGURE 52 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015) 180


【レポートのキーワード】

神経血管用機器、インターベンショナル神経学、医療機器、血管閉塞コイル、ステント、マイクロカテーテル、バルーン閉塞装置、分水装置

★調査レポート[神経血管用機器/インターベンショナル神経学の世界市場予測(~2021年)] ( Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021 / MAM-MD1310) 販売に関する免責事項
[神経血管用機器/インターベンショナル神経学の世界市場予測(~2021年)] ( Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021 / MAM-MD1310) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆